VIGAX
Price
$227.36
Change
-$0.34 (-0.15%)
Updated
Jul 11 closing price
Net Assets
311.95B
WOFRX
Price
$63.76
Change
-$0.27 (-0.42%)
Updated
Jul 11 closing price
Net Assets
1.9B
Interact to see
Advertisement

VIGAX vs WOFRX

Header iconVIGAX vs WOFRX Comparison
Open Charts VIGAX vs WOFRXBanner chart's image
Vanguard Growth Index Admiral
Price$227.36
Change-$0.34 (-0.15%)
VolumeN/A
Net Assets311.95B
Allspring Opportunity R6
Price$63.76
Change-$0.27 (-0.42%)
VolumeN/A
Net Assets1.9B
VIGAX vs WOFRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VIGAX vs. WOFRX commentary
Jul 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VIGAX is a StrongBuy and WOFRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGAX has more cash in the bank: 312B vs. WOFRX (1.9B). VIGAX pays higher dividends than WOFRX: VIGAX (0.45) vs WOFRX (0.00). VIGAX was incepted earlier than WOFRX: VIGAX (25 years) vs WOFRX (5 years). WOFRX (0.77) is less costly to investors than VIGAX (0.05). WOFRX is a more actively managed with annual turnover of: 20.00 vs. VIGAX (11.00). WOFRX has a lower initial minimum investment than VIGAX: WOFRX (0) vs VIGAX (3000). VIGAX annual gain was more profitable for investors over the last year : 15.30 vs. WOFRX (2.50). VIGAX return over 5 years is better than : 108.20 vs. WOFRX (32.87).
VIGAXWOFRXVIGAX / WOFRX
Total Expense Ratio0.050.727%
Annual Report Gross Expense Ratio0.050.776%
Fund Existence25 years5 years-
Gain YTD7.8023.592217%
Front LoadN/AN/A-
Min. Initial Investment30000-
Min. Initial Investment IRAN/AN/A-
Net Assets312B1.9B16,430%
Annual Yield % from dividends0.450.00-
Returns for 1 year15.302.50612%
Returns for 3 years94.6227.45345%
Returns for 5 years108.2032.87329%
Returns for 10 years304.47N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JSEAX21.87N/A
N/A
JPMorgan International Equity A
PHLQX42.79N/A
N/A
PGIM Jennison Health Sciences R6
SILLX27.40N/A
N/A
Franklin Global Equity C
SROAX13.24-0.07
-0.53%
Calamos Antetokounmpo Sustainable Eqs A
MECDX15.72-0.12
-0.76%
NYLI Epoch Capital Growth Class A